Protective features of monoclonal antibodies to Escherichia coli during experimental infection of mice with homologous and heterologous serotypes of E. coli

Journal of Medical Microbiology

Volumn 49, Issue 3, 2000, Pages 253-260

  Raponi, Giammarco ^a   Ghezzi, M Cristina ^a   Lun, Maria T ^a   Bigotti, Giulio ^b   Natali, Pier G ^c   Mancini, Carlo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; ENDOTOXIN; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASCITES FLUID; BACTERIAL INFECTION; CONTROLLED STUDY; ESCHERICHIA COLI; EXPERIMENTAL INFECTION; FEMALE; HISTOLOGY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE;

EID: 0034009197     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-49-3-253     Document Type: Article

References (28)

1. 1. Centres for Disease Control and Prevention. Increase in National Hospital Discharge Survey rates for septicemia. United States 1979-1987. MMWR Morbid Mortal Wkly Rep 1990; 39: 31-34.
2. 2. Young LS, Proctor RA, Beutler B, McCabe WR, Sheagren JN. University of California Davis Interdepartmental Conference on Gram-negative septicemia. Rev Infect Dis 1991; 13: 666-687.
3. 3. Courvalin P. The Garrod Lecture. Evasion of antibiotic action by bacteria. J Antimicrob Chemother 1996; 37: 855-869.
4. 4. Bayston KF, Cohen J. Bacterial endotoxin and current concepts in the diagnosis and treatment of endotoxaemia. J Med Microbiol 1990; 31: 73-83.
5. 5. Fisher CJ, Opal SM, Dahinauf JF et al. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB006 Sepsis Syndrome Study Group. Crit Care Med 1993, 21: 318-327.
6. 6. Teng NNH, Kaplan HS, Herbert JM et al. Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies. Proc Natl Acad Sci USA 1985; 82: 1790-1794.
7. 7. Debroy C, Yealy J, Wilson RA, Bhan MK, Kumar R. Antibodies raised against the Outer Membrane Protein interrupt adherence of enteroaggregative Escherichia coli. Infect Immun 1995; 63: 2873-2879.
8. 8. Salles M-F, Mandine E, Zalisz R, Guenounou M, Smets P. Protective effects of murine monoclonal antibodies in experimental septicemia: E. coli antibodies protect against different serotypes of E. coli. J Infect Dis 1989; 159: 641-647.
9. 9. Baumgartner J-D, Glauser MP, McCutchan JA et al. Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid. Lancet 1985; 2: 59-63.
10. 10. Baumgartner JD, Heumann D, Gerain J, Weinbreck P, Grau GE, Glauser MR Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core antibodies. J Exp Med 1990; 171: 889-896.
11. 11. Baumgartner J-D, Heumann D, Glauser M-P. The HA-IA monoclonal antibody for gram-negative sepsis. N Engl J Med 1991; 325: 281-282.
12. 12. Bhattacharjee AK, Opal SM, Taylor R et al. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Re Chemotype) lipopolysaccharide and Neisseria meningitidis group B Outer Membrane Protein produces protective antibodies against gram-negative bacteremia. J Infect Dis 1996; 173:1157-1163.
13. 13. Ziegler EJ, Fischer CJ, Sprung CL et al. Treatment of gram-negative bacteremia and septic shock with HA-IA human monoclonal antibody against endotoxin. A randomized, doubleblind, placebo-controlled trial. The HA-IA sepsis study group. N Engl J Med 1991; 324: 429-436.
14. 14. Hellman J, Zanzot EM, Loiselle PM et al. Antiserum against Escherichia coli J5 contains antibodies reactive with outer membrane proteins of heterologous gram-negative bacteria. J Infect Dis 1997; 176: 1260-1268.
15. 15. Silva AT, Appelmelk BJ, Cohen J. Purified monoclonal antibody to endotoxin core fails to protect mice from experimental gram-negative sepsis. J Infect Dis 1993; 168: 256-257.
16. 16. Bowden RA, Cloeckaert A, Zygmunt MS, Dubray G. Outer-membrane protein-and rough lipopolysaccharide-specific monoclonal antibodies protect mice against Bnicella ovis. J Med Micmbiol 1995; 43: 344-347.
17. 17. De Sa C, Souriau A, Bernard F, Saunas J, Rodolakis A. An oligomer of the major outer membrane protein of Chlamydia psiltaci is recognized by monoclonal antibodies which protect mice from abortion. Inject Immun 1995; 63: 4912-4916.
18. 18. Helminen ME, Maciver I, Latimer JL, Cope LD, McCracken GH, Hansen EJ. A major outer membrane protein of Moraxella catarrhalis a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model. Infect Immun 1993; 61: 2003-2010.
19. 19. Lun MT, Amatucci AM, Raponi G et al. Murine monoclonal antibody elicited with antibiotic-exposed Escherichia coli exerts protective capacity in experimental bacterial infections. J Med Microbiol 1994; 41: 179-183.
20. 20. Lun MT, Raponi G, Amatucci AM, Natali PG, Fraioli R, Mancini C. Characterisation and protective capacity of monoclonal antibodies elicited in mice against protein epitopes of antibiotic-exposed Escherichia coli. J Med Microbiol 1997; 46: 122-128.
21. 21. von Specht B-U, Knapp B, Muth G et al. Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins. Infect Immun 1995; 63: 1855-1862.
22. 22. Raponi G, Lun MT, Lorino G at al. Reactivity and protective capacity of a polyclonal antiserum derived from mice immunized with antibiotic exposed Escherichia coli. J Antimicrob Chemother 1993; 31: 117-128.
23. 23. Ruff MR, Gifford GE. Purification and physico-chemical characterization of rabbit tumor necrosis factor. J Immunol 1980; 125: 1671-1677.
24. 24. Goldblatt D, Scadding GK, Lund VJ, Wade AM, Turner MW, Pandey JP. Association of Gm allotypes with the antibody response to outer membrane proteins of a common upper respiratory tract organism, Moraxella catarrhalis. J Immunol 1994; 153: 5316-5320.
25. 25. Kervella M, Fauchère J-L, Fourel D, Pagès J-M. Immunological cross-reactivity between outer membrane pore proteins of Campylobacter jejuni and Escherichia coli. FEMS Microbiol Lett 1992; 99: 281-286.
26. 26. Hofstra H, van Tol MJD, Dankert J. Cross-reactivity of major outer membrane proteins of Enterobacteriaceae, studied by crossed immunoelectrophoresis. J Bacteriol 1980; 143: 328-337.
27. 27. Tracey K, Beutler BR, Lowry SF et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470-474.
28. 28. Rietschel ET, Brade H. Bacterial endotoxins. Sci Am 1992; 267: 54-61.